Výsledky vyhledávání

A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy. S3AA3012 Study Group

Autor: B, Needles, E, Miranda, F M, Garcia Rodriguez, L B, Diaz, J, Spector, J, Craig, G, Cohen, S, Krasnow, J, Brogden, M, Ames

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 7(5)

The objectives of this study were to compare the efficacy and safety of orally administered ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with high-dose cisplatin-based chemotherapy (cisplatin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f6082cba32ce627004e485ad5f902443
https://pubmed.ncbi.nlm.nih.gov/10483821

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání